TARO-ZOLEDRONIC ACID CONCENTRATE

Google image searchProduct monograph

Active ingredient

zoledronic acid (zoledronic acid monohydrate), 4 MG/5 ML

DIN: 02415186

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: TO BE DILUTED BEFORE USE. FOR IV INFUSION. 5ML SINGLE DOSE VIAL.

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 26-FEB-2014

ATC:

• M05 — DRUGS FOR TREATMENT OF BONE DISEASES (ATC, ATC/DDD, )
• M05B — DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, ATC/DDD)
• M05BA — Bisphosphonates (ATC, ATC/DDD)
• M05BA08 — ZOLEDRONIC ACID (ATC/DDD)

Reference brand drug: Aclasta

External Links for Taro-Zoledronic Acid Concentrate

Search on Google

• Taro-Zoledronic Acid Concentrate side effects
• Taro-Zoledronic Acid Concentrate dosage
• zoledronic acid side effects
• zoledronic acid dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-zoledronic acid concentrate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.